Gilead Sciences is a Finalist for the PinkNews Awards in the Business Equality Category

Jun 10, 2022 10:25 AM ET

Campaign: Corporate Social Responsibility

Text on pink background, "PinkNews AWARDS 2022"

We’re honored to be to be a finalist for the PinkNews Awards in the Business Equality category. These UK-based awards recognize the contributions of businesses, individuals and organizations who help advance greater LGBTQ+ equality around the world – something we’re continually focused on.

We congratulate our fellow nominees, and we look forward to the ceremony in October.

Originally published by Gilead Sciences

About Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California. Gilead Website

Gilead Sciences is a Finalist for the PinkNews Awards in the Business Equality Category

More from Gilead Sciences

Gilead Helps Pen a Children’s Book for Families Facing Breast Cancer

Gilead Foundation’s Healthcare Education, Access and Leadership (HEAL) Initiative Is Dedicating $5 Million to Help Build a More Diverse Bay Area Healthcare Workforce

Gilead Oncology Grant Supports 22 U.S. Organizations With $3.15 Million to Provide Support to Those Affected By Breast Cancer

Gilead Sciences: New Report Shows Every Country in the World Must Do More To End the HIV Epidemic

Championing HIV Services for LGBTQ+ Youth

Working to Build Next-Generation Cancer Therapies

Helping End HIV - Gilead Sciences

Seramount Ranks Gilead Sciences Among Its Leading Inclusion Index Company